- ►annals.org [PDF] SL Greenspan, HG Bone, MP Ettinger, DA … - Annals of Internal Medicine, 2007 - Am Coll Physicians Susan L. Greenspan, MD; Henry G. Bone, MD; Mark P. Ettinger, MD; David A.
Hanley, MD; Robert Lindsay, MD; Jose R. Zanchetta, MD; Consuelo M. Blosch, MD;
Annette L. Mathisen, PhD; Stephen A. Morris, MD; and Thomas B. Marriott, ... Cited by 86 - Related articles - All 3 versions
DM Black, JP Bilezikian, KE Ensrud, SL … - New England Journal of Medicine, 2005 - content.nejm.org Background Since the use of parathyroid hormone as a treatment for osteoporosis
is limited to two years or less, the question of whether antiresorptive therapy
should follow parathyroid hormone therapy is important. We previously ... Cited by 180 - Related articles - BL Direct - All 9 versions
- ►endojournals.org AB Hodsman, DA Hanley, MP Ettinger, MA … - Journal of Clinical Endocrinology & Metabolism, 2003 - Endocrine Soc Daily sc injections of N-terminal analogs of PTH increase bone mass and decrease
fractures in osteoporotic women. We investigated the efficacy and safety of
human PTH-(1–84) (full-length PTH) in the treatment of postmenopausal ... Cited by 118 - Related articles - BL Direct - All 6 versions
J Fox, MA Miller, RR Recker, SP Bare, SY … - Journal of musculoskeletal & neuronal interactions - ncbi.nlm.nih.gov 1: J Musculoskelet Neuronal Interact. 2005 Oct-Dec;5(4):356-7. Treatment of
postmenopausal osteoporotic women with parathyroid hormone ... Cited by 20 - Related articles - BL Direct - All 3 versions
- ►sagepub.com [PDF] JL Vahle, GG Long, G Sandusky, M Westmore … - Toxicologic pathology, 2004 - tpx.sagepub.com DOI: 10.1080/01926230490462138 2004; 32; 426 Toxicol Pathol John L. Vahle,
Gerald G. Long, George Sandusky, Michael Westmore, Yanfei Linda Ma and Masahiko
Sato ... Bone Neoplasms in F344 Rats Given Teriparatide [rhPTH(1-34)] Are ... Cited by 57 - Related articles - BL Direct - All 6 versions
- ►servier.ch [PDF] E Seeman, B Vellas, C Benhamou, JP Aquino, … - Journal of Bone and Mineral Research, 2006 - Am Soc Bone Min Res Drs Seeman and Reginster serve as consultants, advisory board members, speakers,
and clinical trials investigators during the course of the SOTI and TROPOS
studies. Dr Kaufman serves as a clinical trials investigator and speaker ... Cited by 69 - Related articles - BL Direct - All 8 versions
- ►endojournals.org DM Antoniucci, DE Sellmeyer, JP Bilezikian, … - Journal of Clinical Endocrinology & Metabolism, 2007 - Endocrine Soc Context: The effect of PTH therapy on serum and urinary calcium levels and the
risk of hypercalcemia or hypercalciuria has not been formally evaluated. ...
Objective: The objective was to examine changes in serum and urinary ... Cited by 9 - Related articles - BL Direct - All 3 versions
- ►betterbones.org [PDF] C Deal, M Omizo, EN Schwartz, EF Eriksen, P … - Journal of Bone and Mineral Research, 2005 - Am Soc Bone Min Res We compared combination treatment with teriparatide plus raloxifene with
teriparatide alone in women with postmenopausal osteoporosis in a 6-month
double-blind, placebo-controlled trial that measured biochemical markers of ... Cited by 87 - Related articles - BL Direct - All 11 versions
- ►endojournals.org MJ Horwitz, MB Tedesco, C Gundberg, A … - Journal of Clinical Endocrinology & Metabolism, 2003 - Endocrine Soc PTH-related protein (PTHrP) is homologous with PTH. PTH, an effective anabolic
agent for treating osteoporosis, has been shown to stimulate both bone
resorption by osteoclasts and bone formation by osteoblasts. We examined ... Cited by 84 - Related articles - BL Direct - All 6 versions
MR McClung, J San Martin, PD Miller, R … - Archives of Internal Medicine, 2005 - archinte.highwire.org Background Antiresorptive agents for the treatment of osteoporosis suppress bone
remodeling and reestablish bone turnover at a lower rate to reduce bone loss.
Recombinant teriparatide (human parathyroid hormone 1-34) stimulates bone ... Cited by 80 - Related articles - BL Direct - All 5 versions
